| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000006505 |
| Receipt No. | R000007715 |
| Scientific Title | Study of lipid profile and gene analyses in patients with cardiovascular diseases and lifestyle-related diseases |
| Date of disclosure of the study information | 2011/10/07 |
| Last modified on | 2022/10/20 (Ver. 4) |
| Basic information | ||
| Public title | Study of lipid profile and gene analyses in patients with cardiovascular diseases and lifestyle-related diseases | |
| Acronym | lipid profile and gene analyses in patients with cardiovascular diseases and lifestyle-related diseases | |
| Scientific Title | Study of lipid profile and gene analyses in patients with cardiovascular diseases and lifestyle-related diseases | |
| Scientific Title:Acronym | lipid profile and gene analyses in patients with cardiovascular diseases and lifestyle-related diseases | |
| Region |
|
|
| Condition | |||||||||
| Condition | Cardiovascular diseases/Cerebrovascular diseases/lifestyle-related diseases | ||||||||
| Classification by specialty |
|
||||||||
| Classification by malignancy | Others | ||||||||
| Genomic information | YES | ||||||||
| Objectives | |
| Narrative objectives1 | To explore novel risk factors for cardiovascular diseases and lifestyle- related diseases by analyzing lipid profile and gene polymorphisms. |
| Basic objectives2 | Others |
| Basic objectives -Others | To explore novel risk factors for diseases |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Lipid profile including cholesterol efflux etc.Gene analysis(SNPs,deletion,
insertion,CNV,expression etc) |
| Key secondary outcomes | Blood and urine analyses including Hemoglobin A1c levels, Urinary acid,
Markers indicating obesity (e.g. adiponectin), inflammation (high sensitive CRP), oxidative stress (8-OHdG/ MDA-LDL), early-staged kidney diseases (microalbuminuria) |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Patients with cardiovascular diseases, cerebrovascular diseases and lifestyle-related diseases, and their relatives who are willing to accept the analyses of lipid profile and gene
2)Patients who gave written informed consent |
|||
| Key exclusion criteria | 1)Subjects with known bleeding tendency
2)Subjects with anemia 3)Subjects whose doctor in charge do not agree to join the trial |
|||
| Target sample size | 2300 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | National Defense Medical College | ||||||
| Division name | Department of Internal Medicine1 | ||||||
| Zip code | |||||||
| Address | 3-2 Namiki, Tokorozawa, JAPAN 359-8513 | ||||||
| TEL | 04-2995-1597 | ||||||
| katsunorike@ndmc.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | National Defense Medical College | ||||||
| Division name | Department of Internal Medicine1 | ||||||
| Zip code | |||||||
| Address | 3-2 Namiki, Tokorozawa, JAPAN 359-8513 | ||||||
| TEL | 04-2995-1597 | ||||||
| Homepage URL | |||||||
| ayaori@ndmc.ac.jp | |||||||
| Sponsor | |
| Institute | National Defense Medical College |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Foundation for Promotion of Defense Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 防衛医科大学校
埼玉県立循環器・呼吸器病センター 所沢ハートセンター ひろせクリニック 豊岡第一病院 圏央所沢病院 所沢中央病院 所沢第一病院 東京慈恵会医科大学 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | To analyze lipid profile including cholesterol efflux etc and Gene(SNPs,deletion,insertion,CNV,expression etc) in Cardiovascular disease/Cerebrovascular disease/lifestyle-related disease. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007715 |